For the first time in 2022, Amplifon took part in the CDP Climate Change questionnaire, a non-profit organization which since 2000 has been managing the largest database of greenhouse gas emissions (GHG) at a global level, getting a score of C on a scale from A to F, in line with the industry average.

The FTSE4Good Index Series are share indices launched by the FTSE Group, measuring the companies’ performance in ESG areas. In 2022, Amplifon increased its ESG Rating to 2.8 (on a scale from 0 to 5), higher than the Health Care Industry average (2.3). 

The ISS ESG Corporate Rating provides investors with an overall evaluation of companies' ESG performances and opportunities. In 2022, Amplifon was awarded a rating of C- (on a scale that goes from D- to A+), and the transparency level was confirmed to be high.

Also in 2022, MSCI, whose ESG ratings aim to measure the resilience of companies with regard to ESG risks and trends, confirmed Amplifon’s ESG rating as AA on a scale that goes from CCC to AAA with scores higher than the average in the reference industry and in all key assessment areas.

Standard Ethics, which evaluates companies commitment in terms of international directives and guidelines (e.g., UN, OECD, EU), in 2022 confirmed a Standard Ethics Rating of E+ for Amplifon, on a scale that goes from F to EEE.

The Sustainalytics ESG risk rating assesses companies based on their exposure to the main ESG risks. Thanks to the limited exposure to these types of risks, as well as the correct management of residual and potential risks, in 2022 Amplifon was awarded an ESG risk rating of 14.5/100 (low risk).

In 2022 as well, Amplifon took part in S&P’s 2022 Corporate Sustainability Assessment improving its total score from 55 to 64, on a scale of 0-100, as well as the scores of all the three main dimensions: Governance & Economics (from 53 to 65), Environment (from 47 to 54), Social (from 58 to 65), thereby gaining the 9th position in the “Health Care Providers & Services” industry global classification. Following these results, also this year Amplifon was included in the 2023 Global Sustainability Yearbook, which includes the classification of the 708 top performers out of more than 7,800 companies evaluated by the CSA. Moreover, the Group was recognized as an Industry Mover, achieving the most significant improvement in the industry compared with the previous year.

In 2022, Vigeo Eiris increased Amplifon's Overall ESG Score from 43 to 48 on a scale of 0-100, attributing it a higher ESG performance than the industry average in all three ESG pillars and the position of 10/49 within the reference sector (Health Care Equipment & Services).